Cargando…
Initial In Vivo Quantification of Tc-99m Sestamibi Uptake as a Function of Tissue Type in Healthy Breasts Using Dedicated Breast SPECT-CT
A pilot study is underway to quantify in vivo the uptake and distribution of Tc-99m Sestamibi in subjects without previous history of breast cancer using a dedicated SPECT-CT breast imaging system. Subjects undergoing diagnostic parathyroid imaging studies were consented and imaged as part of this I...
Autores principales: | Mann, Steve D., Perez, Kristy L., McCracken, Emily K. E., Shah, Jainil P., Wong, Terence Z., Tornai, Martin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431100/ https://www.ncbi.nlm.nih.gov/pubmed/22956950 http://dx.doi.org/10.1155/2012/146943 |
Ejemplares similares
-
Reverse perfusion pattern in myocardial spect with 99mTc-SestaMIBI
por: Schillaci, O, et al.
Publicado: (2013) -
Ectopic Submandibular Parathyroid Adenoma by Tc-99m Sestamibi SPECT/CT Localization
por: Ng, Fung Him, et al.
Publicado: (2020) -
Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer
por: O’Connor, Michael K., et al.
Publicado: (2017) -
Utility of (99m)Tc-Sestamibi SPECT/CT in the Early Localization of Metastatic Parathyroid Carcinoma
por: Fernando, Patrick Earl A, et al.
Publicado: (2018) -
Detection of anthracycline-induced cardiotoxicity using perfusion-corrected (99m)Tc sestamibi SPECT
por: Safee, Zaitulhusna M., et al.
Publicado: (2019)